GenesisCare Revenue and Competitors

Sydney, AUS

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • GenesisCare's estimated annual revenue is currently $1.7B per year.(i)
  • GenesisCare's estimated revenue per employee is $378,000

Employee Data

  • GenesisCare has 4598 Employees.(i)
  • GenesisCare grew their employee count by -3% last year.

GenesisCare's People

NameTitleEmail/Phone
1
Patient Services OfficerReveal Email/Phone
2
Senior Patients Services OfficerReveal Email/Phone
3
Senior Director, Division OperationsReveal Email/Phone
4
Clinical Services ManagerReveal Email/Phone
5
IT Service Delivery ManagerReveal Email/Phone
6
CX Insights ManagerReveal Email/Phone
7
Oncology Centre ManagerReveal Email/Phone
8
Talent and Capability PartnerReveal Email/Phone
9
Clinical Pharmacy Product AnalystReveal Email/Phone
10
Clinical NurseReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.1M27314%N/AN/A
#2
$13.1M544%N/AN/A
#3
$29.2M108-31%N/AN/A
#4
$47.8M1617%N/AN/A
#5
$47.2M1599%N/AN/A
#6
$85.5M2885%N/AN/A
#7
$22.4M83-2%N/AN/A
#8
$34.8M129-3%N/AN/A
#9
$44M1483%N/AN/A
#10
$22.4M832%N/AN/A
Add Company

What Is GenesisCare?

We are 5000 highly trained healthcare professionals and support staff across Australia, the U.K., Spain, China and the United States, designing innovative treatments and care for people with cancer and heart disease. Our purpose is to design care experiences that get the best possible life outcomes. We believe care should be focused on the individual, not the condition. That care should be available when and where people need it most. Across the world, we have more than 440 centres to help us bring the right care to our patients. For radiation therapy, that includes 14 centres in the UK, 21 in Spain, 36 in Australia and 300 in the U.S. We also offer cardiology and sleep services at more than 80 locations across Australia. Every year our team sees more than 400,000 people globally. On 15 May 2020, major U.S. integrated cancer care provider 21st Century Oncology officially become part of GenesisCare's leading international oncology network, together with Landmark Cancer Centers. We believe we can achieve more together than apart, combining the best of 21st Century Oncology and GenesisCare, through our shared goals, and experience driving quality care and patient access. We'll also be investing in innovation, technology, research and new systems, which will all help to deliver high quality care to patients in U.S. communities, now and into the future. Our purpose is to design care experiences that get the best possible life outcomes. To give patients high-quality care that's available where and when they need it and is tailored to their particular needs. Care that helps them get on with their life and do the things that are important to them. We do this by approaching care like nobody else.

keywords:N/A

N/A

Total Funding

4598

Number of Employees

$1.7B

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GenesisCare News

2022-04-06 - A Hard Thing to Swallow 5K coming to Tri-Cities raising head ...

Oncology provider GenesisCare has teamed with nonprofit organization ... said Dr. Brian Lawenda, a GenesisCare Radiation Oncologist.

2022-03-30 - Morgan Stanley on board for GenesisCare unit

DataRoom understands that GenesisCare's cardiology unit runs with a doctor equity billing model, where a doctor may work in a variety of...

2022-03-30 - CardiologyCo indicative bids fly, shortlist pending

GenesisCare will get a better idea of buyer interest in its CardiologyCo spin-off on Friday, with first-round bids due to land with sale...

2021-07-23 - Elekta : GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

ATLANTA, July 23, 2021 - Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterloader systems, including service agreements. The cancer treatment devices will allow GenesisCare to continue to invest ...

2021-07-23 - GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices

GenesisCare extends U.S. brachytherapy service with 27 Elekta Flexitron treatment devices Fri, Jul 23, 2021 14:00 CET ATLANTA, July 23, 2021 – Elekta (EKTA-B.ST) announced today that GenesisCare, a leading global provider of integrated cancer care, has ordered 27 Flexitron® brachytherapy afterl ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1459.3M47385%N/A
#2
$300M48335%N/A
#3
$1016.6M48416%N/A
#4
$1500.9M4873N/AN/A
#5
$2467M5422-2%N/A